a Department of Ophthalmology , Ewha Womans University College of Medicine, Mok-dong Hospital , Seoul , South Korea.
b Department of Ophthalmology , National Medical Center , Seoul , South Korea.
Ocul Immunol Inflamm. 2019;27(4):614-621. doi: 10.1080/09273948.2018.1424340. Epub 2018 Feb 8.
: To report a new surgical procedure using biodegradable collagen matrix (Ologen) implantation with conjunctival flap for reconstruction of scleromalacia after periocular surgery. : A total of 26 areas of 25 eyes in 25 patients were included. We divided all eyes according to the preoperative extent of calcified plaque or scleral defect as follows: small, large, and large and severe. Morphologic outcomes were graded from 0 to 7, with higher scores indicating worse cosmetic outcomes. : Mean follow-up period was 8.3 ± 5.6 months. No eyes showed recurrence or specific complications related to Ologen such as implant extrusion or allergic reaction. Minor complications such as flap vessel engorgement and flap hypertrophy were easily treated. Mean morphologic outcome scores were 1.8, 2.4, and 5.3 in groups 1, 2, and 3, respectively. : The combined surgery may be an effective and safe procedure for the treatment of scleromalacia after periocular surgeries.
报告一种新的手术方法，即使用可生物降解胶原基质（Ologen）植入物联合结膜瓣重建眼眶手术后的巩膜软化症。共纳入 25 例 25 只眼的 26 个部位。我们根据术前钙化斑块或巩膜缺损的范围将所有眼分为小、大、大和严重。形态学结果从 0 到 7 分级，分数越高表示美容效果越差。平均随访时间为 8.3±5.6 个月。没有眼出现 Ologen 相关的复发或特定并发症，如植入物挤出或过敏反应。轻微并发症如瓣血管充血和瓣肥厚很容易治疗。第 1、2 和 3 组的平均形态学结果评分分别为 1.8、2.4 和 5.3。联合手术可能是治疗眼眶手术后巩膜软化症的一种有效且安全的方法。
